301 results
Page 2 of 16
8-K
EX-99.1
2ijqat5pfffjpfji62s
8 Aug 23
Theriva™ Biologics Reports Second Quarter 2023 Operational Highlights and Financial Results
8:10am
8-K
EX-99.1
p3q58klyad1p46
2 Aug 23
Regulation FD Disclosure
9:22am
8-K
EX-99.1
fxdhrl
27 Jun 23
Theriva Biologics Announces Orphan Drug Designation Granted by the U.S. FDA for VCN-01 for the Treatment of Pancreatic Cancer
5:11pm
8-K
EX-99.1
02si sl1nwao3hd9
11 May 23
Theriva Biologics Reports First Quarter 2023 Operational Highlights and Financial Results
8:10am
8-K
EX-99.1
3umun4es3ardq8yran3
30 Mar 23
Theriva Biologics Reports Fourth Quarter and Full-Year 2022 Operational Highlights and Financial Results
8:15am
8-K
EX-99.1
u1lcn6 8bos874
10 Nov 22
Theriva Biologics Reports Third Quarter 2022 Operational Highlights and Financial Results
5:11pm
8-K
EX-99.1
07p7mc23mfktctjw6
12 Oct 22
Amendments to Articles of Incorporation or Bylaws
8:15am
8-K
EX-99.1
6qxoy
30 Sep 22
Regulation FD Disclosure
8:10am
8-K
EX-99.1
ze3ws4 lbqd
27 Sep 22
Regulation FD Disclosure
8:16am
424B3
l494 tzjg28ei12bdwh
16 Sep 22
Prospectus supplement
4:15pm
8-K
EX-99.1
7pirv
6 Sep 22
Regulation FD Disclosure
8:10am
8-K
EX-99.1
3kuug ud30cyyw
11 Aug 22
Synthetic Biologics Reports Second Quarter 2022 Operational Highlights and Financial Results
8:15am